NYSEAMERICAN:YCBD cbdMD (YCBD) Stock Price, News & Analysis $0.89 -0.02 (-1.68%) As of 06/30/2025 04:10 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock About cbdMD Stock (NYSEAMERICAN:YCBD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get cbdMD alerts:Sign Up Key Stats Today's Range$0.85▼$0.9650-Day Range$0.82▼$2.1052-Week Range$0.76▼$6.54Volume247,557 shsAverage Volume107,069 shsMarket Capitalization$7.95 millionP/E RatioN/ADividend YieldN/APrice Target$3.00Consensus RatingBuy Company OverviewcbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, and sleep, focus, and calming aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solutions under the hempMD brand. It distributes its products through its e-commerce website, third-party e-commerce sites, select distributors and marketing partners, wholesalers, and various brick and mortar retailers in the United States. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is headquartered in Charlotte, North Carolina.Read More… cbdMD Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks53rd Percentile Overall ScoreYCBD MarketRank™: cbdMD scored higher than 53% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingcbdMD has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoveragecbdMD has only been the subject of 1 research reports in the past 90 days.Read more about cbdMD's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Book Value per Share RatiocbdMD has a P/B Ratio of 0.22. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about cbdMD's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.90% of the float of cbdMD has been sold short.Short Interest Ratio / Days to CovercbdMD has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in cbdMD has recently decreased by 31.25%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldcbdMD does not currently pay a dividend.Dividend GrowthcbdMD does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.90% of the float of cbdMD has been sold short.Short Interest Ratio / Days to CovercbdMD has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in cbdMD has recently decreased by 31.25%, indicating that investor sentiment is improving significantly. News and Social MediaN/ANews SentimentN/A Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, cbdMD insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.10% of the stock of cbdMD is held by insiders.Percentage Held by InstitutionsOnly 7.18% of the stock of cbdMD is held by institutions.Read more about cbdMD's insider trading history. Receive YCBD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for cbdMD and its competitors with MarketBeat's FREE daily newsletter. Email Address YCBD Stock News HeadlinescbdMD grants restricted stock units to directorsMay 21, 2025 | investing.comcbdMD, Inc. (AMEX:YCBD) Q2 2025 Earnings Call TranscriptMay 17, 2025 | msn.comHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First policies, a historic wave of investment is flooding back into the United States: Apple committing a colossal $500 billion to build new U.S. factories. Microsoft injecting $80 billion into domestic manufacturing. Nvidia moving critical chip production back to America. But here's the hidden opportunity: There's now a groundbreaking way for you to start collecting monthly checks from these very same companies— checks that could reach as high as $5,917 each month. Don't miss your chance to participate directly in America's industrial comeback. | Investors Alley (Ad)cbdMD, Inc. (AMEX:YCBD) Q2 2025 Earnings Call TranscriptMay 17, 2025 | msn.comcbdMD Inc (YCBD) Q2 2025 Earnings Call Highlights: Strategic Moves and Financial Improvements ...May 16, 2025 | finance.yahoo.comcbdMD, Inc. (YCBD) Q2 2025 Earnings Call TranscriptMay 15, 2025 | seekingalpha.com3YCBD : An Overview of cbdMD's EarningsMay 15, 2025 | benzinga.comcbdMD, Inc. to Host Conference Call to Discuss March 31, 2025, Second Quarter of Fiscal Year ...May 9, 2025 | gurufocus.comSee More Headlines YCBD Stock Analysis - Frequently Asked Questions How have YCBD shares performed this year? cbdMD's stock was trading at $2.6232 at the start of the year. Since then, YCBD stock has decreased by 66.0% and is now trading at $0.8918. View the best growth stocks for 2025 here. How were cbdMD's earnings last quarter? cbdMD, Inc. (NYSEAMERICAN:YCBD) released its quarterly earnings results on Thursday, December, 16th. The company reported ($25.20) earnings per share (EPS) for the quarter, missing the consensus estimate of ($16.20) by $9.00. The firm earned $9.79 million during the quarter. cbdMD had a negative net margin of 0.81% and a negative trailing twelve-month return on equity of 8.52%. When did cbdMD's stock split? Shares of cbdMD reverse split before market open on Wednesday, May 7th 2025.The 1-8 reverse split was announced on Monday, April 21st 2025. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, May 6th 2025. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split. How do I buy shares of cbdMD? Shares of YCBD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of cbdMD own? Based on aggregate information from My MarketBeat watchlists, some other companies that cbdMD investors own include Village Farms International (VFF), Tilray Brands (TLRY), NVIDIA (NVDA), Roku (ROKU), Organigram Global (OGI), Bristol Myers Squibb (BMY) and Bionano Genomics (BNGO). Company Calendar Last Earnings12/16/2021Today6/30/2025Next Earnings (Estimated)8/13/2025Fiscal Year End9/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorBusiness Services Industry ADVERTISING/MKTG SVCS Sub-IndustryConsumer Goods Current SymbolNYSEAMERICAN:YCBD CIK1644903 Webwww.cbdmd.com Phone(704) 445-3060FaxN/AEmployees90Year FoundedN/APrice Target and Rating Average Stock Price Target$3.00 High Stock Price Target$3.00 Low Stock Price Target$3.00 Potential Upside/Downside+236.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$3.70 million Net Margins-0.81% Pretax Margin-0.81% Return on Equity-8.52% Return on Assets-1.35% Debt Debt-to-Equity RatioN/A Current Ratio0.63 Quick Ratio0.36 Sales & Book Value Annual Sales$19.48 million Price / Sales0.41 Cash FlowN/A Price / Cash FlowN/A Book Value$3.98 per share Price / Book0.22Miscellaneous Outstanding Shares8,910,000Free Float8,721,000Market Cap$7.95 million OptionableNot Optionable Beta2.44 A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report This page (NYSEAMERICAN:YCBD) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredFine. Don’t believe me. They called me an alarmist... When in 2010 I said America’s debt was out of control. When I warned it w...Porter & Company | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredNvidia’s Huang: AI is going to need 100x more power12Nvidia CEO Jensen Huang didn't mince words. After Nvidia's latest earnings call, Huang said AI now requires...Weiss Ratings | SponsoredTrump Makes Major Crypto AnnouncementTrumps “Secret Weapon” for Crypto Dominance There's a growing push for America to lead the next wave of dig...Crypto 101 Media | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding cbdMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share cbdMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.